Cargando…
Treatment with eFT-508 increases chemosensitivity in breast cancer cells by modulating the tumor microenvironment
BACKGROUND: Patients with triple-negative breast cancer (TNBC) are better responders to neoadjuvant chemotherapy; however, they are poor in the durability of response with decreased overall and progression-free survival. METHODS: Given that significant improvements have been reported with PD-L1-PD-1...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206753/ https://www.ncbi.nlm.nih.gov/pubmed/35717238 http://dx.doi.org/10.1186/s12967-022-03474-9 |